The pharmacological potential of novel melittin variants from the honeybee and solitary bees against inflammation and cancer

HIGHLIGHTS

• who: Pelin Erkoc et al. from the Institute of Pharmaceutical Biology, Faculty of Biochemistry, Chemistry and Pharmacy, Goethe University Frankfurt, Frankfurt, Germany have published the research: The Pharmacological Potential of Novel Melittin Variants from the Honeybee and Solitary Bees against Inflammation and Cancer, in the Journal: Toxins 2022, 14, x FOR PEER REVIEW of 28/Oct/2022
• what: The authors focused on melectin from the mourning bee (Melecta albifrons), various xylopins from the Japanese and violet carpenter bee (Xylocopa appendiculata, Xylocopa violacea), osmin from the mason bee (Osmia bicornis), codesane from the silk bee (Colletes . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.